Pathophysiological aspects concerning the treatment of the apallic syndrome.
D000328:Adult; D000405:Akinetic Mutism / Q000188:drug therapy* / Q000503:physiopathology; D001143:Arousal / Q000187:drug effects; D001930:Brain Injuries / Q000150:complications* / Q000503:physiopathology; D002540:Cerebral Cortex / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D011725:Pyridines / Q000627:therapeutic use*; D011746:Pyrithioxin / Q000627:therapeutic use*; D013577:Syndrome
D011725:Pyridines; D011746:Pyrithioxin